![Margareta Elisabeth Björk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Margareta Elisabeth Björk
Director/Board Member at
CAMURUS AB
Net worth: 631 124 $ as of 2026-09-29
Profile
Margareta Elisabeth Björk currently serves as Director at Vicore Pharma AB, Chalmers University of Technology, Björks Matematik o Mera AB, Rfidcompare Europe AB, and Betula Consulting AB. She is Director at Vicore Pharma Holding AB since 2023, Independent Non-Executive Director at Pharvaris NV since 2021, and is set to be Director at Hansa Biopharma AB starting in 2025.
Former roles include Director at Albireo Ltd., Independent Director at Rocket Pharmaceuticals, Inc. from 2020 to 2026, Independent Non-Executive Director at Calliditas Therapeutics AB, Director at Chalmers Ventures AB from 2018 to 2023, Head-Diabetes & Endocrinology Unit at Uppsala University Hospital, Senior VP & Head-Late Stage Development at AstraZeneca PLC, and Associate Professor at the University of Uppsala.
Education includes doctorates from Karolinska Institutet and the University of Uppsala.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHARVARIS N.V. 0.02% | 2026-09-16 | 15,167 ( 0.02% ) | 481 097 $ | 2026-09-29 |
| 2025-12-30 | 1,250 ( 0% ) | 78 230 $ | 2026-09-29 | |
| 2026-09-21 | 74,784 ( 0.03% ) | 71 796 $ | 2026-09-29 | |
| 2026-03-23 | 0 ( -.--% ) | - $ | 2026-09-29 |
Margareta Elisabeth Björk active positions
| Companies | Position | Start |
|---|---|---|
| PHARVARIS N.V. | Director/Board Member | 2021-11-30 |
| VICORE PHARMA HOLDING AB | Director/Board Member | 2022-12-31 |
| CAMURUS AB | Director/Board Member | 2024-12-31 |
| HANSA BIOPHARMA AB | Director/Board Member | 2025-09-01 |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Director/Board Member | - |
Rfidcompare Europe AB | Director/Board Member | - |
Björks Matematik o Mera AB | Director/Board Member | - |
Chalmers University of Technology
 Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
Former positions of Margareta Elisabeth Björk
| Companies | Position | End |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Director/Board Member | 2026-05-19 |
| ░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Education of Margareta Elisabeth Björk
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Calliditas Therapeutics AB
 Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Camurus AB
 Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Health Technology |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Vicore Pharma Holding AB
 Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
Uppsala University Hospital
 Uppsala University Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Health Services |
Chalmers Ventures AB
 Chalmers Ventures AB Investment ManagersFinance Chalmers Ventures invests in companies located across the globe. The firm focuses on binary, technology sector, tech track, chalmers ecosystem and state. It participates in pre-seed, seed, early and growth stage capital requirements with an investment size of SEK 1- 25 million. The firm also makes co-investments and follow-on investments. | Finance |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Björks Matematik o Mera AB | |
Rfidcompare Europe AB |
- Stock Market
- Insiders
- Margareta Elisabeth Björk
